RICH2 is implicated in viraemic control of HIV-1 in black South African individuals.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28069446)

Published in Infect Genet Evol on January 06, 2017

Authors

Maria Paximadis1, Refilwe N Ngqobe2, Richard E Chaisson3, Neil A Martinson4, Caroline T Tiemessen5

Author Affiliations

1: National Institute for Communicable Diseases, Centre for HIV and STIs, Cell Biology, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Electronic address: paxim@nicd.ac.za.
2: National Institute for Communicable Diseases, Centre for HIV and STIs, Cell Biology, Johannesburg, South Africa.
3: Johns Hopkins University Center for AIDS Research, Baltimore, MD, USA.
4: Perinatal HIV Research Unit (PHRU), University of the Witwatersrand, Johannesburg, South Africa; MRC Soweto Matlosana Centre for HIV/AIDS and TB Research, South Africa.
5: National Institute for Communicable Diseases, Centre for HIV and STIs, Cell Biology, Johannesburg, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Articles cited by this

Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics (2004) 125.23

A global reference for human genetic variation. Nature (2015) 12.85

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90

Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA (2008) 6.29

African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet (2008) 6.06

FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res (2006) 5.60

Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68

Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study. J Infect Dis (2009) 3.48

Understanding the benign nature of SIV infection in natural hosts. J Clin Invest (2007) 2.43

Elite control of HIV Infection: implications for vaccines and treatment. Top HIV Med (2007) 2.16

CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort. PLoS One (2014) 2.04

Innate sensing of HIV-1 assembly by Tetherin induces NFκB-dependent proinflammatory responses. Cell Host Microbe (2012) 2.03

A CD317/tetherin-RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells. J Cell Biol (2009) 1.90

Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque. J Clin Invest (2011) 1.61

Retroviral retention activates a Syk-dependent HemITAM in human tetherin. Cell Host Microbe (2014) 1.56

A general role for splicing enhancers in exon definition. RNA (2002) 1.43

HIV-associated chronic immune activation. Immunol Rev (2013) 1.38

Detecting rare variant effects using extreme phenotype sampling in sequencing association studies. Genet Epidemiol (2012) 1.35

Human RhoGAP domain-containing proteins: structure, function and evolutionary relationships. FEBS Lett (2002) 1.27

Host and viral genetic correlates of clinical definitions of HIV-1 disease progression. PLoS One (2010) 1.23

Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis (2010) 1.16

Upregulation of BST-2/Tetherin by HIV infection in vivo. J Virol (2011) 1.09

Emerging role of the host restriction factor tetherin in viral immune sensing. J Mol Biol (2013) 1.03

Africa: the next frontier for human disease gene discovery? Hum Mol Genet (2011) 1.02

Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS. J Acquir Immune Defic Syndr (2011) 0.98

A systematic review of definitions of extreme phenotypes of HIV control and progression. AIDS (2014) 0.96

Human leukocyte antigen class I (A, B, C) and II (DRB1) diversity in the black and Caucasian South African population. Hum Immunol (2011) 0.95

Identification and functional characterization of nadrin variants, a novel family of GTPase activating protein for rho GTPases. J Neurochem (2002) 0.94

Natural control of HIV-1 replication and long-term nonprogression: overlapping but distinct phenotypes. J Infect Dis (2009) 0.89

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load. Proc Natl Acad Sci U S A (2015) 0.87

Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline Among Postpartum Women on Antiretroviral Therapy in South Africa. J Acquir Immune Defic Syndr (2016) 0.86

The role of BST-2/Tetherin in host protection and disease manifestation. Immun Inflamm Dis (2015) 0.79

Influence of intragenic CCL3 haplotypes and CCL3L copy number in HIV-1 infection in a sub-Saharan African population. Genes Immun (2012) 0.77